Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

RIGLRIGL
Showing 8 of 30 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in RIGEL PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 440,626 shares of RIGL (RIGEL PHARMACEUTICALS INC), worth $11.9M as of 2026-Q1. The position was increased (+3.8% shares). RIGL represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$11.9M

Current Shares

440,626

Total Value Change

+$8.7M

Total Shares Change

+49,844

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
440,626
+3.8%
$11.9M0.0%$33.02
29
2025-Q4
Increased
424,314
+0.1%
$18.2M0.0%$42.83
28
2025-Q3
Increased
423,723
+1.9%
$12M0.0%$28.75
28
2025-Q2
Increased
415,607
+1.1%
$7.8M0.0%$19.48
28
2025-Q1
Increased
411,168
+2.3%
$7.4M0.0%$17.88
28
2024-Q4
Increased
402,051
+0.6%
$6.8M0.0%$16.47
27
2024-Q3
Increased
399,663
+2.3%
$6.5M0.0%$16.42
28
2024-Q2
Decreased
390,782
-89.7%
$3.2M0.0%$8.22
0

Other major holders of RIGL: BlackRock, Inc., STATE STREET CORP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used